Repligen

Ultime notizie

Titoli nella lingua originale della fonte.

• Repligen Corporation (RGEN) Stock Price, News, Quote & History (si apre in una nuova scheda)

  Yahoo! Finance Canada · 30 set 2026

• Form 4 Repligen Corporation For: 28 September (si apre in una nuova scheda)

  Investing.com India · 28 set 2026

• After a stock-unit release, Repligen (RGEN) withheld 421 shares from its CFO to cover taxes. (si apre in una nuova scheda)

  Stock Titan · 28 set 2026

• Repligen Rises as Investors Weigh M&A Progress and Fresh Bullish Signals (si apre in una nuova scheda)

  Quiver Quantitative · 28 set 2026

• Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up (si apre in una nuova scheda)

  Eastern Progress · 27 set 2026

• Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound? (si apre in una nuova scheda)

  Eastern Progress · 27 set 2026

• Form 4 Repligen Corporation For: 26 September By Investing.com (si apre in una nuova scheda)

  Investing.com Canada · 26 set 2026

• Repligen CEO Loeillot sells $2.46m in shares By Investing.com (si apre in una nuova scheda)

  Investing.com Canada · 26 set 2026

• Repligen Stock Price Forecast. Should You Buy RGEN? (si apre in una nuova scheda)

  StockInvest.us · 25 set 2026

• Repligen (RGEN) CEO sells shares at $190 each after exercising options under a trading plan. (si apre in una nuova scheda)

  Stock Titan · 25 set 2026

• Repligen Corporation (RGEN) stock price, news, quote and history (si apre in una nuova scheda)

  Yahoo Finance Singapore · 25 set 2026

• Shares valued at $2.46 million are listed for sale by a Repligen (NASDAQ: RGEN) officer and director. (si apre in una nuova scheda)

  Stock Titan · 24 set 2026

• (RGEN) Movement as an Input in Quant Signal Sets (si apre in una nuova scheda)

  Stock Traders Daily · 23 set 2026

• Repligen Corporation stock hits 52-week high at 188.95 USD (si apre in una nuova scheda)

  Investing.com · 23 set 2026

• Repligen (RGEN) CEO sells 5,426 shares under plan (si apre in una nuova scheda)

  Stock Titan · 22 set 2026

• Repligen (NASDAQ: RGEN) insider plans new stock sale after two recent trades (si apre in una nuova scheda)

  Stock Titan · 21 set 2026

• Repligen announces long-serving director Karen Dawes’ retirement (si apre in una nuova scheda)

  tipranks.com · 15 set 2026

• Repligen Corporation (RGEN) Presents at Wells Fargo 21st Annual Healthcare Conference - Slideshow (si apre in una nuova scheda)

  Seeking Alpha · 11 set 2026

• UBS Adjusts Price Target on Repligen to $225 From $195, Keeps Buy Rating (si apre in una nuova scheda)

  Yahoo Finance · 9 set 2026

• 3 Reasons to Avoid RGEN and 1 Stock to Buy Instead (si apre in una nuova scheda)

  Yahoo Finance · 9 set 2026

• Repligen (RGEN) Stock Looks Near Fair Value After Recent Rebound (si apre in una nuova scheda)

  Yahoo Finance · 3 set 2026